Wearable Febrile Neutropenia Monitoring With Multi-Sensor Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective home monitoring systems for detecting medication-induced side effects in patients undergoing cancer treatment, which can be severe and require timely intervention.
Innovation Solution
A system and method for home monitoring of medication-induced side effects using wearable sensors and mobile applications to track patient health metrics and alert healthcare providers when adverse effects are detected.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current monitoring methods are used, then patient safety is compromised due to lack of detection, but implementing comprehensive monitoring systems increases device complexity and cost
Solution Approach 1:
The monitoring system is divided into separate functional modules: wearable sensors for physiological monitoring, mobile application for data processing and alert generation, and notification system for provider alerting. This segmentation allows each component to be optimized independently while working together to detect medication-induced side effects without requiring a monolithic complex system
Solution Approach 2:
The mobile application serves as an intermediary between the wearable sensors and the notification system. It collects data from multiple sensor types, processes the information to identify side effect patterns, and triggers appropriate alerts to healthcare providers, thereby mediating the complex interaction between monitoring components
2Reliability
If real-time monitoring is implemented, then early detection of side effects is achieved, but energy consumption and device power requirements increase
Solution Approach 1:
The wearable sensors perform physiological measurements at periodic intervals rather than continuously, analyzing patient vitals at scheduled times and comparing them against baseline data to detect changes indicative of side effects. This periodic sampling maintains detection capability while significantly reducing energy consumption compared to continuous monitoring
Solution Approach 2:
The mobile application performs local data processing and pattern recognition using the patient's historical baseline information stored on the device, eliminating the need for constant cloud connectivity and reducing energy consumption associated with continuous data transmission while maintaining autonomous detection capability
3Measurement precision
If multiple sensor types are used for comprehensive monitoring, then detection accuracy improves, but device complexity and manufacturing difficulty increase
Solution Approach 1:
The wearable device is designed as a universal platform that can accommodate multiple types of sensors (heart rate, temperature, activity, sleep monitors) that all interface through a common data processing architecture. This multi-functional design allows comprehensive monitoring of various physiological parameters without requiring separate specialized devices for each measurement type
Solution Approach 2:
Multiple sensor functions are merged into a single integrated wearable unit with a unified data processing system. The mobile application consolidates data from all sensor types and performs comprehensive analysis to identify side effect patterns, combining what would otherwise be separate monitoring systems into one cohesive solution
Data Source
AI summary
Systems and methods for home monitoring and detection of febrile neutropenia in a patient are provided. The system includes a photoplethysmographic sensor for sensing photoplethysmographic signals of the patient, and one or more blood borne parameter sensors for sensing parameters in the patient's blood. A febrile neutropenia monitoring application receives information sensed by the photoplethysmography sensor and the one or more blood borne parameter sensors and determines, based on the received information, the presence or deterioration of febrile neutropenia. The method includes the steps of: sensing photoplethysmographic signals of the patient with a photoplethysmographic sensor worn by the patient; sensing blood borne parameters in the patient's blood with one or more blood borne parameter sensors; transmitting the sensed photoplethysmographic signals and blood borne parameters to a febrile neutropenia monitoring application; and determining, by the febrile neutropenia monitoring application, the presence or deterioration of febrile neutropenia based on the received information.